Maynard Um
-
-
-
-
-
-
-
Acumen Pharmaceuticals, Inc. (ABOS) PT Raised to $7 at BTIG
-
-
-
-
-
-
-
Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c
-
-
-
-
-
-
-
Acumen Pharmaceuticals (ABOS) to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Acumen Pharmaceuticals, Inc. (ABOS)
404,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

